InvestSMART

Argent Biopharma Limited (ASX: RGT) - Announcements

Current share price for RGT : $0.033 0.002 (6.45%)+

ASX company news and announcements for Argent Biopharma Limited (RGT) are delayed by 20 minutes from the time of their release between 7.30am and 7.30pm EDT and are in PDF format. All Argent Biopharma Limited (RGT) ASX announcements deemed to be price sensitive will be highlighted with . If you are looking for ASX announcements for companies other than Argent Biopharma Limited (RGT), please use our Company Announcements tool to search across all ASX-listed companies.

Latest company announcements for Argent Biopharma Limited (RGT)

Search all Announcements
Market Cap ($m) Headline Release
date/time+		 Price at
release+		 Current
price+		 Gain/Loss View
$4 Change of Director's Interest Notice - RZ 15 Oct 2024 6:40PM $0.410 $0.033 fallen by 91.95%
$4 s708A Cleansing Notice 15 Oct 2024 5:32PM $0.410 $0.033 fallen by 91.95%
$4 Notification regarding unquoted securities - RGT 15 Oct 2024 5:29PM $0.410 $0.033 fallen by 91.95%
$4 Application for quotation of securities - RGT 15 Oct 2024 5:28PM $0.410 $0.033 fallen by 91.95%
$4 Application for quotation of securities - RGT 15 Oct 2024 5:25PM $0.410 $0.033 fallen by 91.95%
$4 s708A Cleansing Notice 9 Oct 2024 5:43PM $0.550 $0.033 fallen by 94%
$4 Application for quotation of securities - RGT 9 Oct 2024 5:37PM $0.550 $0.033 fallen by 94%
$4 Refinancing of Convertible Security Agreement 9 Oct 2024 9:51AM $0.565 $0.033 fallen by 94.16%
$4 Results of Meeting 1 Oct 2024 7:22PM $0.530 $0.033 fallen by 93.77%
$4 Appendix 4G and Corporate Governance Statement 30 Sep 2024 6:17PM $0.350 $0.033 fallen by 90.57%
$4 Annual Report to Shareholders 30 Sep 2024 6:12PM $0.350 $0.033 fallen by 90.57%
$4 Date of AGM and Closing Date for Director Nominations 25 Sep 2024 4:42PM $0.325 $0.033 fallen by 89.85%
$4 Delisting Update 23 Sep 2024 4:20PM $0.290 $0.033 fallen by 88.62%
$4 Change of Director's Interest Notice - RZ 12 Sep 2024 8:24AM $0.325 $0.033 fallen by 89.85%
$4 CannEpil - Technical Overview 10 Sep 2024 9:11AM $0.360 $0.033 fallen by 90.83%
$4 CimetrA - Technical Overview 9 Sep 2024 8:58AM $0.330 $0.033 fallen by 90%
$4 Company Presentation 6 Sep 2024 8:43AM $0.320 $0.033 fallen by 89.69%
$4 Preliminary Final Report 30 Aug 2024 4:05PM $0.305 $0.033 fallen by 89.18%
$4 Letter from the CEO 27 Aug 2024 3:56PM $0.345 $0.033 fallen by 90.43%
$4 Notice of General Meeting/Proxy Form 27 Aug 2024 3:31PM $0.350 $0.033 fallen by 90.57%
$4 SINTEF Collaboration for Advanced Chronic Wound Management 21 Aug 2024 9:54AM $0.255 $0.033 fallen by 87.06%
$4 Voluntary Delisting from ASX 15 Aug 2024 9:43AM $0.285 $0.033 fallen by 88.42%
$4 Trading Halt 13 Aug 2024 9:12AM $0.285 $0.033 fallen by 88.42%
$4 Quarterly Activities/Appendix 4C Cash Flow Report 30 Jul 2024 9:02AM $0.285 $0.033 fallen by 88.42%
$4 s708A Cleansing Notice 17 Jul 2024 4:19PM $0.290 $0.033 fallen by 88.62%

126 - 150 of 172 results

Page 6 of 7

  • + Company announcements and prices are delayed by least 20 minutes. Prices are indicative only.

DISCLOSURE: InvestSMART Group Limited employees may have an interest in the securities and managed funds displayed via this service. Please refer to our Financial Services Guide for more information.

Data shown on this website is sourced by Morningstar
© Morningstar. All rights reserved. Neither any Morningstar company nor any of their content providers guarantee the data or content contained herein to be accurate, complete or timely nor will they have any liability for its use or distribution. Any general advice has been prepared by Morningstar Australasia Pty Ltd (ABN: 95 090 665 544, AFSL: 240892) and/or Morningstar Research Limited, subsidiaries of Morningstar, Inc, without reference to your objectives, financial situation or needs. You should consider the advice in light of these matters and, if applicable, the relevant Product Disclosure Statement (in respect of Australian products) or Investment Statement (in respect of New Zealand products) before making any decision to invest. No Morningstar-affiliated company or any of their employees is providing you with personalised financial advice. To obtain advice tailored to your particular circumstances, please contact a professional financial adviser. Some material is copyright and published under licence from ASX Operations Pty Limited ACN 004 523 782 ("ASXO"). Data and content is provided for personal use only.